Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omya is a leading global producer of industrial minerals, primarily fillers and pigments derived from calcium carbonate and dolomite, and distributes specialty chemicals. Headquartered in Switzerland (Oftringen, Obwalden), it serves diverse industries including paper, plastics, paints/coatings, construction materials, agriculture, food & beverage, cosmetics/personal care, and environmental products. Notably, Omya is a significant supplier of high-purity excipients and mineral-based ingredients to the pharmaceutical industry. While it is not a biotech or pharma developer and lacks its own clinical pipeline or proprietary therapeutics/platforms, it plays a crucial role in the health/life science value chain by supplying functional ingredients. The company partners with firms for ingredient distribution, exemplified by its March 2025 partnership with ACTV Biotechnology for distributing plant-based bioactive cosmetic ingredients in the US market, reflecting its expansion into advanced ingredient solutions for personal care/life sciences. Founded in 1884, Omya remains privately owned with operations spanning over fifty countries worldwide and approximately 8,000 employees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omya.